Complement Deposition and Cell Death after Myoblast Transplantation
One of the problems limiting myoblast transplantation (MT) is the early death of the transplanted cells. Because complement can be fixed by myoblasts in vitro, and because it has the capacity to induce cell lysis, its possible role in the early death of transplanted myoblasts was investigated. CD1 m...
Main Authors: | Daniel Skuk, Jacques P. Tremblay Ph.D. |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
1998-09-01
|
Series: | Cell Transplantation |
Online Access: | https://doi.org/10.1177/096368979800700501 |
Similar Items
-
Losartan Enhances the Success of Myoblast Transplantation
by: Raouia Fakhfakh, et al.
Published: (2012-02-01) -
Fibrin Gel Improves the Survival of Transplanted Myoblasts
by: Catherine Gerard, et al.
Published: (2012-02-01) -
Control of Inflammatory Damage by Anti-Lfa-1: Increase Success of Myoblast Transplantation
by: Benoit Guérette, et al.
Published: (1997-03-01) -
AG490 Improves the Survival of Human Myoblasts in Vitro and in Vivo
by: Catherine Gérard, et al.
Published: (2012-12-01) -
Cell Therapy in Myology: Dynamics of Muscle Precursor Cell Death after Intramuscular Administration in Non-human Primates
by: Daniel Skuk, et al.
Published: (2017-06-01)